Pharmaceutical executive to discuss medical business ethics.
Steve Worland, Ph.D., President and CEO of eFFECTOR Therapeutics will be speaking in the Hamilton-Williams Campus Center (Benes B room) on Mar. 24 at 7:30 p.m. Steve Worland co-founded eFFECTOR in 2012 in order to develop new cancer treatments based on recent understanding of how cancers commandeer a newly recognized form of gene regulation. Dr. Worland was a National Institutes of Health Postdoctoral Fellow in Molecular Biology at Harvard University. This event is open and free to the public.
OWU Sponsoring Organization/Office: The Woltemade Center.
Contact: Stacie Ernst at wcenter@owu.edu.